Heart of Texas
Purple Cancer Warriors

   A Website Devoted to Promoting Awareness of a Promising New Drug That Kills Breast Cancer Cells, Developed by
Dr. Alexzander A. A. Asea, PhD.
NampEVA..........

A word that is music to the ears of those of us who have suffered from breast cancer.  Our goal is to provide awareness that there is progress being made in finding a treatment for this dreaded disease that strikes so many women every year.

The Heart of Texas Purple Cancer Warriors
501 (c) (3) Tax Exempt Organization
Dr. Alexzander Asea, PhD
Drug Research
Memorials Purple Cancer Warriors
Memorials
About Us Purple Cancer Warriors
About Us
NampEVA - Purple Cancer Warriors
NampEVA
Photos from Purple Cancer Warriors
Photos
Event Schedule
Merchandise
Welcome to the

Heart of Texas Purple
Cancer Warriors
501 (c) (3) Tax Exempt Organization

We are a group of cancer
survivors who are devoted to
supporting research of a new
protein-based cancer drug
developed by Dr. Alexzander
Asea, PhD, & his research
team.  The new drug,
NampEVA, holds great
promise in fighting breast
cancer, prostate cancer,
kidney cancer, and cancers
of the nervous system.

Members of the Heart of
Texas Purple Cancer
Warriors non-profit
organization have been
working almost non-stop to
bring awareness to Dr.
Asea's Research of
NampEVA.  Our group,
which consists of seven
members, believes that this
new protein-based drug is
one of the greatest
advancements in medical
science in recent years.

NampEVA not only kills the
cancer cells but activates the
immune system to fight
cancer for life.

Please check back often for
the latest information
concerning our organization
and this amazing new drug,
NampEVA.
History
History of the Purple Cancer Warriors
Read more about NampEVA
Please donate to Dr. Asea's Research to battle Cancer
The main goal of the Heart of Texas Purple Cancer Warriors Organization is to bring awareness to a wonderful new drug, NampEVA, that shows great promise in the fight against breast cancer.  The protein-based drug targets and kills triple-negative breast cancer cells and stimulates the immune system to continue killing the cancer cells for life-long protection.

Another goal of the Purple Cancer Warriors is to help raise enough funding for Phase I clinical trials of Dr. Alexzander Asea's newly-developed, protein-based cancer drug that shows so much promise in the search for a cure of this dreaded disease.  Dr. Asea PhD., is a world-renowned doctor and Chief of Scott & White's Investigative Pathology Division in Temple, Texas.

NampEVA pre-clinical trials have been completed and once we have the needed $4.5M to $5M to produce enough of the drug, Phase I clinical trials can begin.  Once approved by the FDA for breast cancer, research is already in place to treat prostate cancer, uterine cancer, kidney cancer, and cancers of the nervous system.

We hope that you will open your hearts and donate to this cause so that Phase I clinical trials can begin the journey to pave the way for lives to be saved from this deadly disease, cancer.  It is important to note that 100% of all funds raised for this cause will go directly to Dr. Asea's NampEVA research. 
Schedule a 'Meet the Enemy' Tour
Visit us on FaceBook
Dr. Alexander Asea's Bio
Drug Research of NampEVA
"Silencing Hsp25/Hsp27 Gene Expression Augment Proteasome Activity and Increases CD8+ T-Cell-mediated Tumor Killing and Memory Responses" is the title of the recent article Dr. Alexzander Asea and his research team published in the journal 'Cancer Prevention Research'. The article can be found in the January 2012 issue, Volume 5, Number 1, Pages 122-137.

This article is the scientific basis for the drug NampEVA and demonstrates that the medical community has accepted and validated Dr. Asea's cutting edge breast cancer research.   Read the complete publication.
Close to a Cure Video
Scientific Basis for NampEVA
sitemap
.
Photos - 2012 Events
Agenda
Heart of Texas Purple Cancer Warriors
Board of Directors Meeting
Donation in Memory of Julie Allison Keener
Donation in Memory of Johnny Leschber
Donation in Memory of Nita Higgins